Clear Harbor Asset Management, LLC Kymera Therapeutics, Inc. Transaction History
Clear Harbor Asset Management, LLC
- $1.13 Billion
- Q1 2024
A detailed history of Clear Harbor Asset Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Clear Harbor Asset Management, LLC holds 10,000 shares of KYMR stock, worth $298,500. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$298,500
Previous $254,000
58.27%
% of portfolio
0.04%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding KYMR
# of Institutions
164Shares Held
63.1MCall Options Held
39.7KPut Options Held
9.7K-
Price T Rowe Associates Inc Baltimore, MD6.33MShares$189 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$179 Million3.05% of portfolio
-
Atlas Venture Life Science Advisors, LLC5.38MShares$161 Million27.05% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$154 Million6.22% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$142 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.63B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...